TY - JOUR
T1 - Compensatory capabilities of islets of BB Wor rats exposed to sustained hyperglycemia
AU - Komiya, I.
AU - Baetens, D.
AU - Kuwajima, M.
AU - Orci, L.
AU - Unger, Roger H
N1 - Funding Information:
From the Center for Diabetes Research and Departmeni of Internal Medicine of the University of Texas Southwestern Medical Center, and Veterans Administration Medical Center, Dallas, TX; and the Instiiut d’Histologie et d’Embryologie, Universitie de Geneve, Geneva, Switzerland. Supported by Veterans Administration Institutional Research Support Grant No. 549-8000. National Institutes of Health Grant No. DKO2700-29, by a Diabetes Research and Education Foundation grant, and by Swiss National Science Foundation Grant No. 3.404.86. Dr Vnger is a Senior Medical Investigator, Dallas Veterans Administration. Address reprint requests to R.H. Unger, MD, Centerfor Diabetes Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd. Dallas, TX 75235. Q 1990 by W.B. Saunders Company. 0026-0495/90/3906-0012$03.00/0
PY - 1990/6
Y1 - 1990/6
N2 - To determine if discordance for autoimmune diabetes in genetically homogeneous animals might reflect differences in the compensatory capacity of their β cells, the glycemic responses of diabetes-prone BB Wor rats during a high rate infusion of 50% glucose were compared with normal and with 40% pancreatectomized Wistar rats similarly infused. In all three groups, the initially severe hyperglycemia declined after the first 48 hours to below the target level of 300 mg/dL despite an increasing rate of glucose infusion. The glycemic profile did not differ from controls and was lower than that of the partially depancreatized rats. Five of 20 hyperglycemic BB Wor rats became diabetic during the 12-day infusion of 50% glucose; there was no difference between their glucose profiles and those of the 15 prediabetic BB Wor rats that remained nondiabetic throughout the period of hyperglycemic infusion. The latter group of BB Wor rats, many of which would ultimately have become diabetic, exhibited a 2.4-fold increase in the volume density of their β cells, compared with a 2.1-fold increase in the Wistar controls. This clinical and morphologic evidence of β-cell compensation in diabetes-prone rats, even in on the verge of overt diabetes, excludes the possibility that subnormal compensation by β cells contributes to diabetes in the BB Wor rat.
AB - To determine if discordance for autoimmune diabetes in genetically homogeneous animals might reflect differences in the compensatory capacity of their β cells, the glycemic responses of diabetes-prone BB Wor rats during a high rate infusion of 50% glucose were compared with normal and with 40% pancreatectomized Wistar rats similarly infused. In all three groups, the initially severe hyperglycemia declined after the first 48 hours to below the target level of 300 mg/dL despite an increasing rate of glucose infusion. The glycemic profile did not differ from controls and was lower than that of the partially depancreatized rats. Five of 20 hyperglycemic BB Wor rats became diabetic during the 12-day infusion of 50% glucose; there was no difference between their glucose profiles and those of the 15 prediabetic BB Wor rats that remained nondiabetic throughout the period of hyperglycemic infusion. The latter group of BB Wor rats, many of which would ultimately have become diabetic, exhibited a 2.4-fold increase in the volume density of their β cells, compared with a 2.1-fold increase in the Wistar controls. This clinical and morphologic evidence of β-cell compensation in diabetes-prone rats, even in on the verge of overt diabetes, excludes the possibility that subnormal compensation by β cells contributes to diabetes in the BB Wor rat.
UR - http://www.scopus.com/inward/record.url?scp=0025306676&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025306676&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(90)90028-B
DO - 10.1016/0026-0495(90)90028-B
M3 - Article
C2 - 2191190
AN - SCOPUS:0025306676
SN - 0026-0495
VL - 39
SP - 614
EP - 618
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 6
ER -